Prevalence and Risk Factors of Asymptomatic Peripheral Arterial Disease in Patients with COPD in Taiwan

PLoS ONE

Volumn 8, Issue 5, 2013, Pages

  Lin, Ming Shian ^a,b   Hsu, Kun Yen ^a   Chen, Yi Jen ^a,b   Chen, Cheng Ren ^a   Chen, Chuan Mu ^d   Chen, Wei ^a,c,d  

^a CHIA YI CHRISTIAN HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

^c CHINA MEDICAL UNIVERSITY   (Taiwan)

^d NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

BRONCHODILATING AGENT;

ADULT; AGE; AGED; ANKLE BRACHIAL INDEX; ARTICLE; ASYMPTOMATIC DISEASE; CARDIOVASCULAR RISK; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; DISEASE ASSOCIATION; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; LUNG FUNCTION TEST; MALE; OBESITY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PREVALENCE; RISK ASSESSMENT; RISK FACTOR; SMOKING HABIT; TAIWAN;

AGED; FEMALE; HUMANS; MALE; PERIPHERAL ARTERIAL DISEASE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK FACTORS; TAIWAN;

EID: 84878090512     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0064714     Document Type: Article

References (37)

1. Mannino DM, Buist AS, (2007) Global burden of COPD: risk factors, prevalence, and future trends. Lancet 370: 765-773.
2. Buist AS, Vollmer WM, Sullivan SD, Weiss KB, Lee TA, et al. (2005) The Burden of Obstructive Lung Disease Initiative (BOLD): rationale and design. COPD 2: 277-283.
3. Fang X, Wang X, Bai C, (2011) COPD in China: the burden and importance of proper management. Chest 139: 920-929.
4. Mathers CD, Loncar D, (2006) Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med 3: e442.
5. Hunninghake DB, (2005) Cardiovascular disease in chronic obstructive pulmonary disease. Proc Am Thorac Soc 2: 44-49.
6. Magnussen H, Watz H, (2009) Systemic inflammation in chronic obstructive pulmonary disease and asthma: relation with comorbidities. Proc Am Thorac Soc 6: 648-651.
7. Garcia-Rio F, Miravitlles M, Soriano JB, Munoz L, Duran-Tauleria E, et al. (2010) Systemic inflammation in chronic obstructive pulmonary disease: a population-based study. Respir Res 11: 63.
8. Yang Z, Knight CA, Mamerow MM, Vickers K, Penn A, et al. (2004) Prenatal environmental tobacco smoke exposure promotes adult atherogenesis and mitochondrial damage in apolipoprotein E-/- mice fed a chow diet. Circulation 110: 3715-3720.
9. Lee SY, Suh JK, Choi JH, Jeon WJ, Cheong MA, (2010) Effect of ketorolac and diclofenac on the impairment of endothelium-dependent relaxation induced by reactive oxygen species in rabbit abdominal aorta. Korean J Anesthesiol 59: 196-202.
10. Arunachalam G, Sundar IK, Hwang JW, Yao H, Rahman I, (2010) Emphysema is associated with increased inflammation in lungs of atherosclerosis-prone mice by cigarette smoke: implications in comorbidities of COPD. J Inflamm (Lond) 7: 34.
11. Engstrom G, Hedblad B, Janzon L, Valind S, (2000) Respiratory decline in smokers and ex-smokers-an independent risk factor for cardiovascular disease and death. J Cardiovasc Risk 7: 267-272.
12. Sin DD, Wu L, Man SF, (2005) The relationship between reduced lung function and cardiovascular mortality: a population-based study and a systematic review of the literature. Chest 127: 1952-1959.
13. Wood-Baker R, Cochrane B, Naughton MT, (2010) Cardiovascular mortality and morbidity in chronic obstructive pulmonary disease: the impact of bronchodilator treatment. Intern Med J 40: 94-101.
14. Gillum RF, (1990) Peripheral arterial occlusive disease of the extremities in the United States: hospitalization and mortality. Am Heart J 120: 1414-1418.
15. Golomb BA, Dang TT, Criqui MH, (2006) Peripheral arterial disease: morbidity and mortality implications. Circulation 114: 688-699.
16. Castagna O, Boussuges A, Nussbaum E, Marqueste L, Brisswalter J, (2008) Peripheral arterial disease: an underestimated aetiology of exercise intolerance in chronic obstructive pulmonary disease patients. Eur J Cardiovasc Prev Rehabil 15: 270-277.
17. Blum A, Simsolo C, Sirchan R, Haiek S, (2011) "Obesity paradox" in chronic obstructive pulmonary disease. Isr Med Assoc J 13: 672-675.
18. Pecci R, De La Fuente Aguado J, Sanjurjo Rivo AB, Sanchez Conde P, Corbacho Abelaira M, (2012) Peripheral arterial disease in patients with chronic obstructive pulmonary disease. Int Angiol 31: 444-453.
19. Soriano JB, Alfageme I, Almagro P, Casanova C, Esteban C, et al. (2012) Distribution and prognostic validity of the new GOLD grading classification. Chest.
20. Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, et al. (2007) Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 176: 532-555.
21. Belch JJ, Topol EJ, Agnelli G, Bertrand M, Califf RM, et al. (2003) Critical issues in peripheral arterial disease detection and management: a call to action. Arch Intern Med 163: 884-892.
22. Weitz JI, Byrne J, Clagett GP, Farkouh ME, Porter JM, et al. (1996) Diagnosis and treatment of chronic arterial insufficiency of the lower extremities: a critical review. Circulation 94: 3026-3049.
23. Wohlfahrt P, Palous D, Ingrischova M, Krajcoviechova A, Seidlerova J, et al. (2011) A high ankle-brachial index is associated with increased aortic pulse wave velocity: the Czech post-MONICA study. Eur J Cardiovasc Prev Rehabil 18: 790-796.
24. Schroeder EB, Welch VL, Evans GW, Heiss G, (2005) Impaired lung function and subclinical atherosclerosis. The ARIC Study. Atherosclerosis 180: 367-373.
25. Zureik M, Benetos A, Neukirch C, Courbon D, Bean K, et al. (2001) Reduced pulmonary function is associated with central arterial stiffness in men. Am J Respir Crit Care Med 164: 2181-2185.
26. Taneda K, Namekata T, Hughes D, Suzuki K, Knopp R, et al. (2004) Association of lung function with atherosclerotic risk factors among Japanese Americans: Seattle Nikkei Health Study. Clin Exp Pharmacol Physiol 31 Suppl 2: S31-34.
27. Schroeder EB, Welch VL, Couper D, Nieto FJ, Liao D, et al. (2003) Lung function and incident coronary heart disease: the Atherosclerosis Risk in Communities Study. Am J Epidemiol 158: 1171-1181.
28. Barr RG, Ahmed FS, Carr JJ, Hoffman EA, Jiang R, et al. (2012) Subclinical atherosclerosis, airflow obstruction and emphysema: the MESA Lung Study. Eur Respir J 39: 846-854.
29. Daskalopoulou SS, Pathmarajah M, Kakkos SK, Daskalopoulos ME, Holloway P, et al. (2008) Association between ankle-brachial index and risk factor profile in patients newly diagnosed with intermittent claudication. Circ J 72: 441-448.
30. Ix JH, Biggs ML, Kizer JR, Mukamal KJ, Djousse L, et al. (2011) Association of body mass index with peripheral arterial disease in older adults: the Cardiovascular Health Study. Am J Epidemiol 174: 1036-1043.
31. Jakovljevic B, Stojanov V, Lovic D, Paunovic K, Radosavljevic V, et al. (2011) Obesity and fat distribution as predictors of aortoiliac peripheral arterial disease in middle-aged men. Eur J Intern Med 22: 84-88.
32. Giugliano G, Brevetti G, Laurenzano E, Brevetti L, Luciano R, et al. (2010) The prognostic impact of general and abdominal obesity in peripheral arterial disease. Int J Obes (Lond) 34: 280-286.
33. McDermott MM, Criqui MH, Ferrucci L, Guralnik JM, Tian L, et al. (2006) Obesity, weight change, and functional decline in peripheral arterial disease. J Vasc Surg 43: 1198-1204.
34. Celli BR, MacNee W, (2004) Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 23: 932-946.
35. Remels AH, Gosker HR, Langen RC, Schols AM, (2012) The mechanisms of cachexia underlying muscle dysfunction in COPD. J Appl Physiol.
36. Eagan TM, Gabazza EC, D'Alessandro-Gabazza C, Gil-Bernabe P, Aoki S, et al. (2012) TNF-alpha is associated with loss of lean body mass only in already cachectic COPD patients. Respir Res 13: 48.
37. Chen YJ, Lin MS, Hsu KY, Chen CR, Chen CM, et al. (2013) Prevalence of asymptomatic peripheral arterial disease and related risk factors in younger and elderly patients in Taiwan. Angiology.